nach oben

Seminars in Immunopathology

Erschienen in:

01.03.2005

Natural antibodies and the autoimmunity of atherosclerosis

verfasst von: Christoph J. Binder, Gregg J. Silverman

Erschienen in: Seminars in Immunopathology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

In recent years, the subject of natural antibodies has been revisited and the immunobiological roles of these humoral factors are being better defined. These antibodies are secreted by distinct sets of innate-like B cells, B-1 cells and marginal zone B cells, which arise early in development to become the sources of “natural immune memory”. Due to their interactions with a variety of self-determinants, natural antibodies have previously been postulated to play roles in the maintenance of host homeostasis. A central paradigm has recently been developed from the demonstration that oxidation derived epitopes on apoptotic cells and oxidized low-density lipoproteins are recognized by the phosphorylcholine-specific germline encoded B-1 cell natural antibody, T15, which has provided important insights into possible “house-keeping” functions under both normal and pathological conditions. In this review, the potential functions of natural antibodies in the pathogenesis and progression of the chronic inflammatory condition of atherosclerosis are discussed, as well as their capacities for apoptotic cell binding and clearance. These interactions of natural antibodies and oxidation-epitopes from phospholipids appear to provide a dynamic immunobiological connection linking host responses in infection, autoimmunity and atherosclerosis.

Ameli S, Hultgeardh-Nilsson A, Regnstrom J, et al (1996) Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 16:1074

Aprahamian T, Rifkin I, Bonegio R, et al (2004) Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 199:1121

Arnold LW, Spencer DH, Clarke SH, et al (1993) Mechanisms that limit the diversity of antibody: three sequentially acting mechanisms that favor the spontaneous production of germline encoded anti-phosphatidyl choline. Int Immunol 5:1365

Baumgarth N, Herman OC, Jager GC, et al (1999) Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 96:2250

Bendelac A, Bonneville M, Kearney JF (2001) Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 1:177

Binder CJ, Chang MK, Shaw PX, et al (2002) Innate and acquired immunity in atherogenesis. Nat Med 8:1218

Binder CJ, Hartvigsen K, Chang MK, et al (2004) IL-5 links adaptive and natural immunity specific for epitopes of Oxidized LDL and protects from atherosclerosis. J Clin Invest 114:427

Binder CJ, Hörkkö S, Dewan A, et al (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9:736

Bird DA, Gillotte KL, Horkko S, et al (1999) Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci USA 96:6347

10.

Boring L, Gosling J, Cleary M, et al (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894

11.

Bos NA, Cebra JJ, Kroese FG (2000) B-1 cells and the intestinal microflora. Curr Top Microbiol Immunol 252:211

12.

Boulanger CM, Scoazec A, Ebrahimian T, et al (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104:2649

13.

Briles DE, Forman C, Hudak S, et al (1982) Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156:1177

14.

Brown M, Schiffman G, Rittenberg MB (1984) Subpopulations of antibodies to phosphocholine in human serum. J Immunol 132:1323

15.

Buono C, Come CE, Witztum JL, et al (2002) Influence of C3 deficiency on atherosclerosis. Circulation 105:3025

16.

Caligiuri G, Nicoletti A, Poirier B, et al (2002) Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 109:745

17.

Campos RA, Szczepanik M, Itakura A, et al (2003) Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 198:1785

18.

Casali P, Schettino EW (1996) Structure and function of natural antibodies. Curr Top Microbiol Immunol 210:167

19.

Chang MK, Bergmark C, Laurila A, et al (1999) Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 96:6353

20.

Chang MK, Binder CJ, Torzewski M, et al (2002) C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 99:13043

21.

Chisolm GM, Steinberg D (2000) The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28:1815

22.

Clarke SH, Arnold LW (1998) B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M⁺ B cell precursor in B-1 cell differentiation. J Exp Med 187:1325

23.

Cocca BA, Cline AM, Radic MZ (2002) Blebs and apoptotic bodies are B cell autoantigens. J Immunol 169:159

24.

Cocca BA, Seal SN, D’Agnillo P, et al (2001) Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci USA 98:13826

25.

Cocca BA, Seal SN, D’Agnillo P, et al (2001) Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci USA 98:13826

26.

Coutinho A, Kazatchkine MD, Avrameas S (1995) Natural autoantibodies. Curr Opin Immunol 7:812

27.

Dansky HM, Charlton SA, Harper MM, et al (1997) T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 94:4642

28.

Daugherty A, Purae E, Delfel-Butteiger D, et al (1997) The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest 100:1575

29.

Dong ZM, Brown AA, Wagner DD (2000) Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 101:2290

30.

Ehrenstein MR, Cook HT, Neuberger MS (2000) Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 191:1253

31.

Ehrenstein MR, O’Keefe TL, Davies SL, et al (1998) Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 95:10089

32.

Erkkila AT, Narvanen O, Lehto S, et al (2000) Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 20:204

33.

Febbraio M, Hajjar DP, Silverstein RL (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785

34.

Febbraio M, Podrez EA, Smith JD, et al (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105:1049

35.

Feeney AJ (1992) Comparison of junctional diversity in the neonatal and adult immunoglobulin repertoires. Int Rev Immunol 8:113

36.

Fogelman AM, Shechter I, Seager J, et al (1980) Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 77:2214

37.

Fossati-Jimack L, Ioan-Facsinay A, Reininger L, et al (2000) Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J Exp Med 191:1293

38.

Freigang S, Hörkkö S, Miller E, et al (1998) Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18:1972

39.

Friedman P, Hörkkö S, Steinberg D, et al (2002) Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration. J Biol Chem 277:7010

40.

George J, Afek A, Gilburd B, et al (1998) Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138:147

41.

Gilbert D, Lopez B, Parain J, et al (2000) Overlap of the anti-cardiolipin and anti-nucleosome responses of the (NZW × BXSB)F1 mouse strain: a new pattern of cross-reactivity for lupus-related autoantibodies. Eur J Immunol 30:3271

42.

Glass CK, Witztum JL (2001) Atherosclerosis: the road ahead. Cell 104:503

43.

Gosling J, Slaymaker S, Gu L, et al (1999) MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103:773

44.

Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21:1876

45.

Hansson GK, Holm J, Jonasson L (1989) Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135:169

46.

Hansson GK, Libby P, Schonbeck U, et al (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91:281

47.

Hardy RR, Hayakawa K (2001) B cell development pathways. Annu Rev Immunol 19:595

48.

Hardy RR, Wei CJ, Hayakawa K (2004) Selection during development of VH11⁺ B cells: a model for natural autoantibody-producing CD5⁺ B cells. Immunol Rev 197:60

49.

Harnett W, Harnett MM (1999) Phosphorylcholine: friend or foe of the immune system? Immunol Today 20:125

50.

Haury M, Sundblad A, Grandien A, et al (1997) The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 27:1557

51.

Hayakawa K, Asano M, Shinton SA, et al (1999) Positive selection of natural autoreactive B cells. Science 285:113

52.

Hayakawa K, Asano M, Shinton SA, et al (2003) Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J Exp Med 197:87

53.

Herzenberg LA, Herzenberg LA (1989) Toward a layered immune system. Cell 59:953

54.

Herzenberg LA, Kantor AB (1993) B-cell lineages exist in the mouse. Immunol Today 14:79

55.

Hörkkö S, Binder CJ, Shaw PX, et al (2000) Immunological responses to oxidized LDL. Free Radic Biol Med 28:1771

56.

Hörkkö S, Bird DA, Miller E, et al (1999) Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103:117

57.

Hörkkö S, Miller E, Branch DW, et al (1997) The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci USA 94:10356

58.

Hörkkö S, Olee T, Mo L, et al (2001) Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein. Circulation 103:941

59.

Hsieh CC, Yen MH, Liu HW, et al (2000) Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. Atherosclerosis 151:481

60.

Huber J, Vales A, Mitulovic G, et al (2002) Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 22:101

61.

Hulthe J, Bokemark L, Fagerberg B (2001) Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men. Arterioscler Thromb Vasc Biol 21:101

62.

Hulthe J, Wiklund O, Hurt-Camejo E, et al (2001) Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2). Arterioscler Thromb Vasc Biol 21:269

63.

Ishida H, Hastings R, Kearney J, et al (1992) Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175:1213

64.

Jonasson L, Holm J, Skalli O, et al (1986) Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131

65.

Kagan VE, Borisenko GG, Serinkan BF, et al (2003) Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine. Am J Physiol Lung Cell Mol Physiol 285:L1

66.

Kantor AB, Merrill CE, Herzenberg LA, et al (1997) An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 158:1175

67.

Karvonen J, Paivansalo M, Kesaniemi YA, et al (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108:2107

68.

Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747

69.

Kearney JF (2000) Immune recognition of OxLDL in atherosclerosis. J Clin Invest 105:1683

70.

Kenny JJ, Derby EG, Yoder JA, et al (2000) Positive and negative selection of antigen-specific B cells in transgenic mice expressing variant forms of the V(H)1 (T15) heavy chain. Int Immunol 12:873

71.

Khoo JC, Miller E, Pio F, et al (1992) Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler Thromb 12:1258

72.

Kim SJ, Gershov D, Ma X, et al (2002) I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196:655

73.

Kopf M, Brombacher F, Hodgkin PD, et al (1996) IL-5-deficient mice have a developmental defect in CD5⁺ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15

74.

Lalor PA, Morahan G (1990) The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol 20:485

75.

Lauber K, Bohn E, Krober SM, et al (2003) Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717

76.

Lorimore SA, Coates PJ, Wright EG (2003) Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 22:7058

77.

Lucas M, Stuart LM, Savill J, et al (2003) Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol 171:2610

78.

Lutz HU, Bussolino F, Flepp R, et al (1987) Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA 84:7368

79.

Major AS, Fazio S, Linton MF (2002) B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 22:1892

80.

Mallat Z, Benamer H, Hugel B, et al (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101:841

81.

Mallat Z, Besnard S, Duriez M, et al (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17

82.

Mallat Z, Hugel B, Ohan J, et al (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99:348

83.

Martin F, Kearney JF (2000) B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”. Immunol Rev 175:70

84.

Masmoudi H, Mota-Santos T, Huetz F, et al (1990) All T15 Id-positive antibodies (but not the majority of VHT15⁺ antibodies) are produced by peritoneal CD5⁺ B lymphocytes. Int Immunol 2:515

85.

McDaniel LS, Benjamin WJ, Forman C, et al (1984) Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia. J Immunol 133:3308

86.

McMurray HF, Parthasarathy S, Steinberg D (1993) Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest 92:1004

87.

Mevorach D, Mascarenhas JO, Gershov D, et al (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313

88.

Mi QS, Zhou L, Schulze DH, Fischer RT, et al (2000) Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. Proc Natl Acad Sci USA 97:6031

89.

Moon BG, Takaki S, Miyake K, et al (2004) The Role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J Immunol 172:6020

90.

Navab M, Ananthramaiah GM, Reddy ST, et al (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45:993

91.

Nicoletti A, Kaveri S, Caligiuri G, et al (1998) Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 102:910

92.

Nilsson J, Calara F, Regnstrom J, et al (1997) Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. J Am Coll Cardiol 30:1886

93.

Nisitani S, Tsubata T, Murakami M, et al (1995) Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur J Immunol 25:3047

94.

O’Garra A, Chang R, Go N, et al (1992) Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22:711

95.

Palinski W, Hörkkö S, Miller E, et al (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 98:800

96.

Palinski W, Miller E, Witztum JL (1995a) Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 92:821

97.

Palinski W, Ord VA, Plump AS, et al (1994) ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 14:605

98.

Palinski W, Tangirala RK, Miller E, et al (1995b) Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 15:1569

99.

Palinski W, Witztum JL (2000) Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 247:371

100.

Palinski W, Ylä-Herttuala S, Rosenfeld ME, et al (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10:325

101.

Paulsson G, Zhou X, Tornquist E, et al (2000) Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 20:10

102.

Pinderski LJ, Fischbein MP, Subbanagounder G, et al (2002) Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 90:1064

103.

Podrez EA, Poliakov E, Shen Z, et al (2002) Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 277:38503

104.

Quinn MT, Parthasarathy S, Steinberg D (1988) Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85:2805

105.

Reardon CA, Blachowicz L, White T, et al (2001) Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21:1011

106.

Reardon CA, Miller ER, Blachowicz L, et al (2004) Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res 45:1347

107.

Roselaar SE, Kakkanathu PX, Daugherty A (1996) Lymphocyte populations in atherosclerotic lesions of apoE-/- and LDL receptor-/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 16:1013

108.

Rosen A, Casciola-Rosen L (2001) Clearing the way to mechanisms of autoimmunity. Nat Med 7:664

109.

Salonen JT, Ylä-Herttuala S, Yamamoto R, et al (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883

110.

Savill J, Dransfield I, Gregory C, et al (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965

111.

Schenkein HA, Berry CR, Purkall D, et al (2001) Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins. Infect Immun 69:6612

112.

Schönbeck U, Libby P (2001) CD40 signaling and plaque instability. Circ Res 89:1092

113.

Seidl KJ, MacKenzie JD, Wang D, et al (1997) Frequent occurrence of identical heavy and light chain Ig rearrangements. Int Immunol 9:689

114.

Seidl KJ, Wilshire JA, MacKenzie JD, et al (1999) Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. Proc Natl Acad Sci USA 96:2262

115.

Shaw PX, Goodyear CS, Chang MK, et al (2003) The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol 170:6151

116.

Shaw PX, Hörkkö S, Chang MK, et al (2000) Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105:1731

117.

Shaw PX, Hörkkö S, Tsimikas S, et al (2001) Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 21:1333

118.

Sigal NH, Gearhart PJ, Klinman NR (1975) The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice. J Immunol 114:1354

119.

Snapper CM, Shen Y, Khan AQ, et al (2001) Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol 22:308

120.

Solvason N, Chen X, Shu F, et al (1992) The fetal omentum in mice and humans. A site enriched for precursors of CD5 B cells early in development. Ann N Y Acad Sci 651:10

121.

Song L, Leung C, Schindler C (2001) Lymphocytes are important in early atherosclerosis. J Clin Invest 108:251

122.

Steinberg D (2002) Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8:1211

123.

Steinberg D, Parthasarathy S, Carew TE, et al (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915

124.

Steinbrecher UP, Parthasarathy S, Leake DS, et al (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883

125.

Stemme S, Faber B, Holm J, et al (1995) T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92:3893

126.

Stemme S, Holm J, Hansson GK (1992) T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 12:206

127.

Su I, Tarakhovsky A (2000) B-1 cells: orthodox or conformist? Curr Opin Immunol 12:191

128.

Subbanagounder G, Watson AD, Berliner JA (2000) Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Radic Biol Med 28:1751

129.

Suzuki H, Kurihara Y, Takeya M, et al (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292

130.

Takabe W, Kanai Y, Chairoungdua A, et al (2004) Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction ofl-type amino acid transporter 1 and cell surface antigen 4F2. Arterioscler Thromb Vasc Biol

131.

Takahashi M, Okazaki H, Ogata Y, et al (2002) Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 161:387

132.

Takatsu K (1998) Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev 9:25

133.

Tatu C, Ye J, Arnold LW, et al (1999) Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med 190:903

134.

Thurnheer MC, Zuercher AW, Cebra JJ, Bos NA (2003) B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice. J Immunol 170:4564

135.

Tome ME, Lutz NW, Briehl MM (2003) Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI72 cells. Biochim Biophys Acta 1642:149

136.

Tsimikas S, Bergmark C, Beyer RW, et al (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41:360

137.

Tsimikas S, Lau HK, Han KR, et al (2004) Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109:3164

138.

Vink A, Warnier G, Brombacher F, et al (1999) Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med 189:1413

139.

Virella G, Atchley D, Koskinen S, et al (2002) Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. Clin Immunol 105:81

140.

Virella G, Koskinen S, Krings G, et al (2000) Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. Clin Immunol 95:135

141.

Wardemann H, Boehm T, Dear N, et al (2002) B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 195:771

142.

Wu R, Shoenfeld Y, Sherer Y, et al (2003) Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations—possible immunomodulation of atherosclerosis. Autoimmunity 36:91

143.

Yamada Y, Doi T, Hamakubo T, et al (1998) Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell Mol Life Sci 54:628

144.

Ylä-Herttuala S, Palinski W, Butler SW, et al (1994) Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14:32

145.

Yoshida T, Ikuta K, Sugaya H, et al (1996) Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 4:483

146.

Zhou X, Caligiuri G, Hamsten A, et al (2001) LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21:108

Titel: Natural antibodies and the autoimmunity of atherosclerosis
verfasst von: Christoph J. Binder
Gregg J. Silverman
Publikationsdatum: 01.03.2005
Verlag: Springer-Verlag
Erschienen in: Seminars in Immunopathology / Ausgabe 4/2005
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-004-0185-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2005

Antibodies as defensive enzymes

B cell superantigens: a microbe’s answer to innate-like B cells and natural antibodies

Development of B cells producing natural autoantibodies to thymocytes and senescent erythrocytes

Natural antibodies and innate-like B cells

Natural serum IgM maintains immunological homeostasis and prevents autoimmunity